Compare Allbirds Inc (BIRD) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs Zimmer Biomet Holdings Inc — how do they compare? Allbirds Inc trades at $2.95 (market cap $26.33M), while Zimmer Biomet Holdings Inc trades at $90.5 (market cap $18.20B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 691.2× Allbirds Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.02% dividend while Allbirds Inc pays none. Which is the better fit depends on your goals.
| BIRD | ZBH | |
|---|---|---|
Market Cap | $26.33M | $18.20B |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $107.71 |
52-Week Low | $2.39 | $79.58 |
Enterprise Value | $45.20M | $25.25B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIRD (Smartbird) trades at $3.00, down 4.15% today, amid a complete pivot from footwear to AI infrastructure. The stock shows a bearish technical signal with flat support/resistance at $3.00, while oscillators like RSI indicate oversold conditions. Financially, revenue has declined from $298M in 2022 to $152M in 2025, with persistent net losses and negative cash flow. Recent news highlights the rebrand to Smartbird and new CEO appointment, driving volatility.
The outlook is highly speculative; the AI pivot offers growth potential but execution risks are severe given the company's unprofitable history and cash burn. Analyst consensus is cautious with 79% hold ratings. Investors face significant uncertainty around the new business model's viability and funding needs.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
